II. Pathophysiology
- Superior Vena Cava Obstruction to flow
- Internal Vascular Invasion
- Vena cava thrombosis (uncommon complication of implantable devices, pacers, AICD, Dialysis Catheter)
- Tumor infiltration
- External Compression (e.g. right lung or Mediastinal Mass)
- Most common Mediastinal Masses include Lung Cancer and Lymphoma
- Mediastinal Mass gradually compresses superior vena cava, blocking entry into right atrium
- Results in retrograde flow and regional edema
- Internal Vascular Invasion
- Superior Vena Cava Obstruction Compensation
- SVC is a thin walled, low pressure large vein 2 cm in width and 4-6 cm in diameter
- Upper body venous engorgement distributes the fluid
- High venous pressures within SVC may be compensated with collateral circulation over 1-2 weeks
- Example: Azygous vein may provide some collateral drainage
III. Causes
- Malignancy (60% of all cases)
- Bronchogenic Carcinoma (80% of malignancy causes)
- Malignant Lymphoma (15% of malignancy causes)
- Metastatic Disease (to lung, mediastinum or Lymph Nodes)
- Breast adenocarcinoma
- Testicular seminoma
- Vena Cava thrombosis (majority of non-malignant cases)
- Long-term venous catheters (40% of thrombosis cases)
- Idiopathic
- Behcet's Syndrome
- Polycythemia Vera
- Paroxysmal Nocturnal Hemoglobinuria
- Long-term shunts
- Long-term Pacemakers
- Other Benign Disease (Rare)
- Mediastinal fibrosis
- Post-Radiation Therapy
- Idiopathic
- Histoplasmosis
- Actinomycosis
- Tuberculosis
- Benign Mediastinal tumor
- Aortic aneurysm
- Dermoid tumor
- Goiter
- Sarcoidosis
- Mediastinal fibrosis
IV. Symptoms
- Presentations are typically subacute and progressive
-
Dyspnea (50%)
- Worse with bending forward
- Neck and facial swelling (40-82%)
- Head fullness or pressure Sensation
- Provoked by lying supine
- Swelling of trunk and upper extremities (40%)
- Local Airway Compression
- Cough
- Dysphagia
- Choking Sensation
- Hoarseness
- Lacrimation
- Nasal Congestion
-
Headache
- Common presenting complaint
- Secondary to Increased Intracranial Pressure
- Referred Pain
- Neurologic
- Dizziness (provoked by bending forward)
- Visual changes or Blurred Vision
- Headaches
- Syncope
- Altered Mental Status
V. Signs: General
- Thoracic chest vein distention (65%)
- Neck vein distention (55%)
- Facial Edema (55%)
- Tachypnea (40%)
- Plethora of the face and Cyanosis (15%)
- Edema of upper extremities (10%)
- Paralysis of Vocal Cords (3%)
- Horner's Syndrome (3%)
- Distended antecubital veins
- Tongue Swelling
- Clear lungs despite Dyspnea and Tachypnea
VI. Signs: Provocative
- Pemberton's Sign
- Patient elevates both arms overhead and observe face for one minute
- Positive if significant facial swelling (plethora), Cyanosis, increased Dyspnea or Lightheadedness within the first minute
- Bendopnea
- Patient bends forward at waist and observed for 30 seconds
- Increased Shortness of Breath within 30 seconds is considered positive
- Also seen with CHF, pulmonary fibrosis
VII. Associated Conditions
VIII. Differential Diagnosis
IX. Imaging
-
Chest XRay
- Mass identified in 90%
- Right superior mediastinum widening (75%)
- Hilar Adenopathy (50%)
- Right Pleural Effusion (25%)
-
Chest CT with IV Contrast (preferred)
- Identifies mass lesions and sites of SVC obstruction and thrombosis
- Collateral vessel development is a sensitive and specific marker of SVC Syndrome
- Test Specificity: 96%
- Test Sensitivity: 92%
-
Ultrasound
- Consider in the evaluation for upper extremity Deep Vein Thrombosis
- Other Imaging modalities
- MR Venogram
- Cavogram
X. Management
- Severity of airway and vascular compromise varies by timing of progression
- Rapid progression may not allow for compensation, resulting in acute airway compromise (uncommon)
- Supportive care for airway compromise
- ABC Management
- High-Dose Corticosteroids
- Most effective in steroid-responsive malignancy such as Lymphoma or thymoma
- Elevate the head of the bed
- Avoid Diuretics
- Identify mass etiology
- Reduction in mass size
- Emergent Intervention RadiologyConsultation
- Other modalities
- Radiation Therapy (e.g. Non-Small Cell Lung Cancer)
- Chemotherapy
- Surgical decompression
- Consult Oncology and Cardiothoracic Surgery acutely
- Palliative CareConsultation once stabilized
-
Anticoagulation with Heparin
- Indicated for venous thrombosis
- Consult for catheter directed Thrombolysis or thrombectomy in hemodynamically Unstable Patients
- Endovascular stenting
- Common acute management with 85 to 100% success rate
- Improvement is seen within days
- Effective even when tumor mass is not reducible
XI. Prognosis
- Poor prognostic sign
- Predicts 90% mortality in 3 years
- Median survival: 6 months
XII. References
- Long, Long and Koyfman (2020) Crit Dec Emerg Med 34(11): 17-24
- Swaminathan and Hedayati (2022) EM:Rap 22(6): 7-9
- Higdon (2018) Am Fam Physician 97(11):741-8 [PubMed]